ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,5,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
3,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
5,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
5,2,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
5,3,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
5,4,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
6,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,2,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
7,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
7,2,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
7,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
7,4,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
8,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
8,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
9,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
10,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,2,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
11,3,Tracheal disorder,Tracheal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
12,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
12,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,5,Headache,Headaches NEC,Headaches,Nerv,N
12,6,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
12,7,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12,9,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
14,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
14,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
15,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
16,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
17,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
19,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
20,2,Pituitary tumour recurrent,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
21,1,Colonic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
22,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
23,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
23,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
23,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
23,4,Headache,Headaches NEC,Headaches,Nerv,N
23,5,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
23,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
24,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
24,2,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
24,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
25,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
28,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
29,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
30,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
30,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
31,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
31,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
32,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,2,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
32,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
32,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
33,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
34,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
34,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
35,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
36,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
37,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
37,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
37,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
37,4,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,5,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
37,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
37,7,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
37,8,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
37,9,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
37,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
37,11,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
37,12,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
38,1,Acromegaly,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
38,2,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
38,3,Fungal oesophagitis,Fungal infections NEC,Fungal infectious disorders,Infec,N
38,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
38,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
40,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
40,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
40,4,Headache,Headaches NEC,Headaches,Nerv,N
40,5,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
40,6,Urethral stenosis,Structural and obstructive urethral disorders (excl congenital),Urethral disorders (excl calculi),Renal,N
40,7,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
40,8,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
41,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
42,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
42,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
43,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
44,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
44,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
44,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
45,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
46,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
46,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
46,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
46,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
46,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
47,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
47,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
48,1,Device leakage,Device issues NEC,Device issues,Prod,N
48,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
48,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
48,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
49,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
49,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
50,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
50,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
50,3,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
51,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
51,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
52,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
53,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
54,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
54,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
54,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
55,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
55,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
56,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
56,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
57,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
58,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
58,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
59,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
60,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
61,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
62,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
63,1,Headache,Headaches NEC,Headaches,Nerv,N
63,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
64,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
64,2,Tracheostomy,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
65,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
65,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
65,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
66,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
68,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
68,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
68,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
69,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
70,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
71,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
72,1,Headache,Headaches NEC,Headaches,Nerv,N
73,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
74,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
74,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
75,1,Headache,Headaches NEC,Headaches,Nerv,N
76,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
77,1,Failed in vitro fertilisation,Reproductive tract and breast procedural complications,Procedural related injuries and complications NEC,Inj&P,N
78,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
78,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
79,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
80,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
81,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
82,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
83,1,Intracranial mass,Structural brain disorders NEC,Structural brain disorders,Nerv,N
83,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
84,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
85,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
86,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
87,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
87,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
88,1,Headache,Headaches NEC,Headaches,Nerv,N
89,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
90,1,Endocrine gland operation,Endocrine gland therapeutic procedures NEC,Endocrine gland therapeutic procedures,Surg,N
91,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
92,1,Pituitary gland operation,Pituitary and hypothalamic therapeutic procedures,Endocrine gland therapeutic procedures,Surg,N
93,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
93,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
93,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
93,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
94,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
95,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
96,1,Headache,Headaches NEC,Headaches,Nerv,N
97,1,Incorrect dosage administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
97,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
